Johnson Matthey plc

Headquarters: London, United Kingdom

Founded: 1817

Employees: 13,258

show_chart LSE: JMAT -2.68%

Market Cap

£3.91 Billion

GBP as of Jan. 1, 2023

US$4.71 Billion

history Market Cap History

Johnson Matthey plc market capitalization over time

Evolution of Johnson Matthey plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Johnson Matthey plc

Detailed Description

Johnson Matthey Plc provides specialty chemicals in the United States, Germany, rest of Europe, the United States, rest of North America, China, rest of Asia, and internationally. It operates through four segments: Clean Air, Efficient Natural Resources, Health, and New Markets. The Clean Air segment provides catalysts for emission control after-treatment systems to remove harmful emissions from vehicles. This segment also offers catalysts for light duty vehicles powered by diesel and gasoline, heavy duty diesel trucks, buses, and non- road equipment. The Efficient Natural Resources segment provides products and processing services for the use and transformation of critical natural resources including oil, gas, biomass, and platinum group metals. The Health segment develops and manufactures active pharmaceutical ingredients (API) for various treatments. The New Markets segment offers battery materials, battery systems, and fuel cell technologies; science and technology to develop the products for devices used in medical procedures; and catalysts to pharmaceutical and agricultural chemicals markets. The company was formerly known as Johnson & Cock and changed its name to Johnson Matthey Plc in 1851. Johnson Matthey Plc was founded in 1817 and is based in London, the United Kingdom.

Stocks & Indices

Johnson Matthey plc has the following listings and related stock indices.

Stock: LSE: JMAT

Stock: FSX: JMT2


Product & Services

Emission control catalysts, industrial catalysts, absorbents, process technologies, fine chemicals, active pharmaceutical ingredients, chemical products, medical device components, colours, coatings, fuel cell technology, battery technology

Key People

Patrick Thomas (chair­person)  Liam Condon (CEO)


Revenue: £15,673 million (2021)

Operating income: £323 million (2021)

Net income: £205 million (2021)



25 Farringdon Street

5th Floor

London, EC4A 4AB

United Kingdom

Phone: 44 20 7269 8400

Fax: 44 20 7269 8433